729 Targeting epidermal growth factor receptor (EGFR)-expressing solid tumors with AFM24, a novel CD16A bispecific innate cell engager: comprehensive correlative science findings from a phase 1 study

Authors :: Gabriele Hintzen
Susanne Wingert
Michael Emig
Pilar Nava-Parada
Kerstin Pietzko
Laura Kohlhas
Uwe Reusch
Melissa Berrien-Elliott
Todd Fehniger
Mark Foster
Paolo Nuciforo
Ester Castillo Andreo
Sina Staeble
Paulien Ravenstijn
Bettina Rehbein
Erich Rajkovic
Arndt Schottelius
Joachim Koch
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools